About Integrated DNA Technologies (IDT)
Founded in 1987, Integrated DNA Technologies (IDT) specialises in the design and manufacture of nucleic acid products that support genomics, molecular biology and clinical research. The company develops custom oligonucleotides, synthetic genes and genomic tools that enable researchers to analyse, modify and detect nucleic acids with high specificity and reproducibility. Its expertise spans PCR, qPCR, next-generation sequencing (NGS), CRISPR genome editing, RNA interference, synthetic biology and molecular diagnostics, supporting applications across academic, biotechnology, pharmaceutical and clinical laboratories.
IDT’s portfolio includes custom DNA and RNA oligonucleotides, PrimeTime™ qPCR and digital PCR assays, xGen™ NGS reagents, Alt-R™ CRISPR genome editing systems and gBlocks™ Gene Fragments for synthetic biology workflows. The company also provides RNA synthesis products, hybridisation probes, gene assembly solutions and nucleic acid controls for assay development and validation. These technologies support workflows ranging from target discovery and gene expression analysis to sequencing, genome engineering and diagnostic assay development.
Europa Biosite’s subsidiaries distribute for Integrated DNA Technologies (IDT) in Switzerland.